|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 519/00 | |
| C07D 493/04 | |||
| C07D 513/04 | |||
| A61P 7/02 | |||
| A61K 31/498 | |||
| A61K 31/501 | |||
| A61K 31/506 |
| (11) | Patento numeris | 3484894 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17742926.3 |
| Europos patento paraiškos padavimo data | 2017-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/041880 |
| Data | 2017-07-13 |
| (87) | Numeris | WO 2018/013776 |
| Data | 2018-01-18 |
| (30) | Numeris | Data | Šalis |
| 201662362121 P | 2016-07-14 | US |
| (72) |
ZHANG, Xiaojun, US
PRIESTLEY, Eldon Scott, US
HALPERN, Oz Scott, US
JIANG, Wen, US
REZNIK, Samuel Kaye, US
RICHTER, Jeremy M., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS |
| TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS |